nodes	percent_of_prediction	percent_of_DWPC	metapath
Allopurinol—XDH—Azathioprine—systemic scleroderma	0.407	0.59	CbGbCtD
Allopurinol—AOX1—Methotrexate—systemic scleroderma	0.154	0.223	CbGbCtD
Allopurinol—SLC22A7—Methotrexate—systemic scleroderma	0.0801	0.116	CbGbCtD
Allopurinol—SLC22A8—Methotrexate—systemic scleroderma	0.0489	0.0708	CbGbCtD
Allopurinol—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000165	0.000534	CcSEcCtD
Allopurinol—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000165	0.000533	CcSEcCtD
Allopurinol—Diarrhoea—Captopril—systemic scleroderma	0.000165	0.000533	CcSEcCtD
Allopurinol—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000165	0.000532	CcSEcCtD
Allopurinol—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000165	0.000532	CcSEcCtD
Allopurinol—Erectile dysfunction—Prednisone—systemic scleroderma	0.000164	0.00053	CcSEcCtD
Allopurinol—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000164	0.00053	CcSEcCtD
Allopurinol—Feeling abnormal—Leflunomide—systemic scleroderma	0.000164	0.000529	CcSEcCtD
Allopurinol—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000164	0.000528	CcSEcCtD
Allopurinol—Nausea—Mometasone—systemic scleroderma	0.000163	0.000527	CcSEcCtD
Allopurinol—Anorexia—Lisinopril—systemic scleroderma	0.000163	0.000526	CcSEcCtD
Allopurinol—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000163	0.000525	CcSEcCtD
Allopurinol—Weight increased—Prednisone—systemic scleroderma	0.000162	0.000524	CcSEcCtD
Allopurinol—Ataxia—Methotrexate—systemic scleroderma	0.000162	0.000524	CcSEcCtD
Allopurinol—Pain—Mycophenolic acid—systemic scleroderma	0.000162	0.000523	CcSEcCtD
Allopurinol—Constipation—Mycophenolic acid—systemic scleroderma	0.000162	0.000523	CcSEcCtD
Allopurinol—Hyperglycaemia—Prednisone—systemic scleroderma	0.000161	0.000519	CcSEcCtD
Allopurinol—Hypotension—Lisinopril—systemic scleroderma	0.00016	0.000515	CcSEcCtD
Allopurinol—Dizziness—Captopril—systemic scleroderma	0.000159	0.000515	CcSEcCtD
Allopurinol—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000159	0.000513	CcSEcCtD
Allopurinol—Depression—Prednisone—systemic scleroderma	0.000159	0.000512	CcSEcCtD
Allopurinol—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000158	0.000511	CcSEcCtD
Allopurinol—Urticaria—Leflunomide—systemic scleroderma	0.000158	0.00051	CcSEcCtD
Allopurinol—Abdominal pain—Leflunomide—systemic scleroderma	0.000157	0.000507	CcSEcCtD
Allopurinol—Body temperature increased—Leflunomide—systemic scleroderma	0.000157	0.000507	CcSEcCtD
Allopurinol—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000156	0.000504	CcSEcCtD
Allopurinol—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000156	0.000504	CcSEcCtD
Allopurinol—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000156	0.000504	CcSEcCtD
Allopurinol—Neuropathy peripheral—Prednisone—systemic scleroderma	0.000156	0.000503	CcSEcCtD
Allopurinol—Breast disorder—Methotrexate—systemic scleroderma	0.000156	0.000503	CcSEcCtD
Allopurinol—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000156	0.000502	CcSEcCtD
Allopurinol—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.000155	0.000501	CcSEcCtD
Allopurinol—Hypersensitivity—Azathioprine—systemic scleroderma	0.000155	0.000501	CcSEcCtD
Allopurinol—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000155	0.000501	CcSEcCtD
Allopurinol—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000155	0.0005	CcSEcCtD
Allopurinol—Insomnia—Lisinopril—systemic scleroderma	0.000154	0.000499	CcSEcCtD
Allopurinol—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000154	0.000498	CcSEcCtD
Allopurinol—Paraesthesia—Lisinopril—systemic scleroderma	0.000153	0.000495	CcSEcCtD
Allopurinol—Vomiting—Captopril—systemic scleroderma	0.000153	0.000495	CcSEcCtD
Allopurinol—Rash—Captopril—systemic scleroderma	0.000152	0.000491	CcSEcCtD
Allopurinol—Dermatitis—Captopril—systemic scleroderma	0.000152	0.00049	CcSEcCtD
Allopurinol—Somnolence—Lisinopril—systemic scleroderma	0.000152	0.00049	CcSEcCtD
Allopurinol—Headache—Captopril—systemic scleroderma	0.000151	0.000488	CcSEcCtD
Allopurinol—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000151	0.000487	CcSEcCtD
Allopurinol—Dyspepsia—Lisinopril—systemic scleroderma	0.00015	0.000485	CcSEcCtD
Allopurinol—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.00015	0.000484	CcSEcCtD
Allopurinol—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.00015	0.000484	CcSEcCtD
Allopurinol—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.00015	0.000483	CcSEcCtD
Allopurinol—Oedema—Mycophenolate mofetil—systemic scleroderma	0.00015	0.000483	CcSEcCtD
Allopurinol—Asthma—Methotrexate—systemic scleroderma	0.000149	0.000481	CcSEcCtD
Allopurinol—Infection—Mycophenolate mofetil—systemic scleroderma	0.000149	0.00048	CcSEcCtD
Allopurinol—Decreased appetite—Lisinopril—systemic scleroderma	0.000148	0.000479	CcSEcCtD
Allopurinol—Eosinophilia—Methotrexate—systemic scleroderma	0.000148	0.000476	CcSEcCtD
Allopurinol—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000147	0.000476	CcSEcCtD
Allopurinol—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000147	0.000474	CcSEcCtD
Allopurinol—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000147	0.000473	CcSEcCtD
Allopurinol—Hypersensitivity—Leflunomide—systemic scleroderma	0.000146	0.000473	CcSEcCtD
Allopurinol—Pain—Lisinopril—systemic scleroderma	0.000146	0.000472	CcSEcCtD
Allopurinol—Constipation—Lisinopril—systemic scleroderma	0.000146	0.000472	CcSEcCtD
Allopurinol—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000145	0.000469	CcSEcCtD
Allopurinol—Bradycardia—Prednisone—systemic scleroderma	0.000145	0.000469	CcSEcCtD
Allopurinol—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000145	0.000467	CcSEcCtD
Allopurinol—Diarrhoea—Azathioprine—systemic scleroderma	0.000144	0.000465	CcSEcCtD
Allopurinol—Haemoglobin—Prednisone—systemic scleroderma	0.000143	0.000463	CcSEcCtD
Allopurinol—Nausea—Captopril—systemic scleroderma	0.000143	0.000462	CcSEcCtD
Allopurinol—Haemorrhage—Prednisone—systemic scleroderma	0.000143	0.000461	CcSEcCtD
Allopurinol—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000143	0.00046	CcSEcCtD
Allopurinol—Asthenia—Leflunomide—systemic scleroderma	0.000143	0.00046	CcSEcCtD
Allopurinol—Pancytopenia—Methotrexate—systemic scleroderma	0.000142	0.000457	CcSEcCtD
Allopurinol—Feeling abnormal—Lisinopril—systemic scleroderma	0.000141	0.000454	CcSEcCtD
Allopurinol—Pruritus—Leflunomide—systemic scleroderma	0.000141	0.000454	CcSEcCtD
Allopurinol—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.00014	0.000451	CcSEcCtD
Allopurinol—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.00014	0.000451	CcSEcCtD
Allopurinol—Neutropenia—Methotrexate—systemic scleroderma	0.000139	0.00045	CcSEcCtD
Allopurinol—Dysuria—Methotrexate—systemic scleroderma	0.000139	0.00045	CcSEcCtD
Allopurinol—Dizziness—Azathioprine—systemic scleroderma	0.000139	0.000449	CcSEcCtD
Allopurinol—Erectile dysfunction—Methotrexate—systemic scleroderma	0.000137	0.000443	CcSEcCtD
Allopurinol—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000136	0.00044	CcSEcCtD
Allopurinol—Asthenia—Mycophenolic acid—systemic scleroderma	0.000136	0.000439	CcSEcCtD
Allopurinol—Diarrhoea—Leflunomide—systemic scleroderma	0.000136	0.000439	CcSEcCtD
Allopurinol—Urticaria—Lisinopril—systemic scleroderma	0.000136	0.000438	CcSEcCtD
Allopurinol—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000135	0.000437	CcSEcCtD
Allopurinol—Abdominal pain—Lisinopril—systemic scleroderma	0.000135	0.000436	CcSEcCtD
Allopurinol—Body temperature increased—Lisinopril—systemic scleroderma	0.000135	0.000436	CcSEcCtD
Allopurinol—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000134	0.000434	CcSEcCtD
Allopurinol—Pruritus—Mycophenolic acid—systemic scleroderma	0.000134	0.000433	CcSEcCtD
Allopurinol—Vomiting—Azathioprine—systemic scleroderma	0.000134	0.000432	CcSEcCtD
Allopurinol—Eye disorder—Prednisone—systemic scleroderma	0.000133	0.000431	CcSEcCtD
Allopurinol—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000133	0.000429	CcSEcCtD
Allopurinol—Drowsiness—Methotrexate—systemic scleroderma	0.000133	0.000429	CcSEcCtD
Allopurinol—Rash—Azathioprine—systemic scleroderma	0.000133	0.000428	CcSEcCtD
Allopurinol—Dermatitis—Azathioprine—systemic scleroderma	0.000133	0.000428	CcSEcCtD
Allopurinol—Depression—Methotrexate—systemic scleroderma	0.000133	0.000428	CcSEcCtD
Allopurinol—Flushing—Prednisone—systemic scleroderma	0.000132	0.000428	CcSEcCtD
Allopurinol—Headache—Azathioprine—systemic scleroderma	0.000132	0.000426	CcSEcCtD
Allopurinol—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000132	0.000425	CcSEcCtD
Allopurinol—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000132	0.000425	CcSEcCtD
Allopurinol—Dizziness—Leflunomide—systemic scleroderma	0.000131	0.000424	CcSEcCtD
Allopurinol—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.00013	0.00042	CcSEcCtD
Allopurinol—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.00013	0.000419	CcSEcCtD
Allopurinol—Stomatitis—Methotrexate—systemic scleroderma	0.00013	0.000418	CcSEcCtD
Allopurinol—Conjunctivitis—Methotrexate—systemic scleroderma	0.000129	0.000417	CcSEcCtD
Allopurinol—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000129	0.000417	CcSEcCtD
Allopurinol—Immune system disorder—Prednisone—systemic scleroderma	0.000129	0.000416	CcSEcCtD
Allopurinol—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000128	0.000413	CcSEcCtD
Allopurinol—Pain—Mycophenolate mofetil—systemic scleroderma	0.000128	0.000413	CcSEcCtD
Allopurinol—Sweating—Methotrexate—systemic scleroderma	0.000127	0.000411	CcSEcCtD
Allopurinol—Haematuria—Methotrexate—systemic scleroderma	0.000127	0.000409	CcSEcCtD
Allopurinol—Vomiting—Leflunomide—systemic scleroderma	0.000126	0.000408	CcSEcCtD
Allopurinol—Alopecia—Prednisone—systemic scleroderma	0.000126	0.000407	CcSEcCtD
Allopurinol—Hypersensitivity—Lisinopril—systemic scleroderma	0.000126	0.000406	CcSEcCtD
Allopurinol—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000126	0.000406	CcSEcCtD
Allopurinol—Dizziness—Mycophenolic acid—systemic scleroderma	0.000125	0.000405	CcSEcCtD
Allopurinol—Epistaxis—Methotrexate—systemic scleroderma	0.000125	0.000405	CcSEcCtD
Allopurinol—Rash—Leflunomide—systemic scleroderma	0.000125	0.000405	CcSEcCtD
Allopurinol—Dermatitis—Leflunomide—systemic scleroderma	0.000125	0.000404	CcSEcCtD
Allopurinol—Mental disorder—Prednisone—systemic scleroderma	0.000125	0.000404	CcSEcCtD
Allopurinol—Nausea—Azathioprine—systemic scleroderma	0.000125	0.000404	CcSEcCtD
Allopurinol—Headache—Leflunomide—systemic scleroderma	0.000125	0.000402	CcSEcCtD
Allopurinol—Malnutrition—Prednisone—systemic scleroderma	0.000124	0.000401	CcSEcCtD
Allopurinol—Agranulocytosis—Methotrexate—systemic scleroderma	0.000124	0.0004	CcSEcCtD
Allopurinol—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000123	0.000398	CcSEcCtD
Allopurinol—Asthenia—Lisinopril—systemic scleroderma	0.000123	0.000396	CcSEcCtD
Allopurinol—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000122	0.000395	CcSEcCtD
Allopurinol—Pruritus—Lisinopril—systemic scleroderma	0.000121	0.00039	CcSEcCtD
Allopurinol—Vomiting—Mycophenolic acid—systemic scleroderma	0.000121	0.000389	CcSEcCtD
Allopurinol—Haemoglobin—Methotrexate—systemic scleroderma	0.00012	0.000387	CcSEcCtD
Allopurinol—Rash—Mycophenolic acid—systemic scleroderma	0.00012	0.000386	CcSEcCtD
Allopurinol—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000119	0.000386	CcSEcCtD
Allopurinol—Haemorrhage—Methotrexate—systemic scleroderma	0.000119	0.000385	CcSEcCtD
Allopurinol—Hepatitis—Methotrexate—systemic scleroderma	0.000119	0.000385	CcSEcCtD
Allopurinol—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000119	0.000384	CcSEcCtD
Allopurinol—Headache—Mycophenolic acid—systemic scleroderma	0.000119	0.000383	CcSEcCtD
Allopurinol—Pharyngitis—Methotrexate—systemic scleroderma	0.000118	0.000382	CcSEcCtD
Allopurinol—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000118	0.000382	CcSEcCtD
Allopurinol—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000118	0.000382	CcSEcCtD
Allopurinol—Nausea—Leflunomide—systemic scleroderma	0.000118	0.000381	CcSEcCtD
Allopurinol—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000118	0.00038	CcSEcCtD
Allopurinol—Urethral disorder—Methotrexate—systemic scleroderma	0.000117	0.000378	CcSEcCtD
Allopurinol—Diarrhoea—Lisinopril—systemic scleroderma	0.000117	0.000377	CcSEcCtD
Allopurinol—Ill-defined disorder—Prednisone—systemic scleroderma	0.000115	0.000372	CcSEcCtD
Allopurinol—Visual impairment—Methotrexate—systemic scleroderma	0.000115	0.000371	CcSEcCtD
Allopurinol—Anaemia—Prednisone—systemic scleroderma	0.000115	0.000371	CcSEcCtD
Allopurinol—Agitation—Prednisone—systemic scleroderma	0.000114	0.000369	CcSEcCtD
Allopurinol—Angioedema—Prednisone—systemic scleroderma	0.000114	0.000367	CcSEcCtD
Allopurinol—Dizziness—Lisinopril—systemic scleroderma	0.000113	0.000365	CcSEcCtD
Allopurinol—Erythema multiforme—Methotrexate—systemic scleroderma	0.000113	0.000364	CcSEcCtD
Allopurinol—Nausea—Mycophenolic acid—systemic scleroderma	0.000113	0.000364	CcSEcCtD
Allopurinol—Malaise—Prednisone—systemic scleroderma	0.000112	0.000362	CcSEcCtD
Allopurinol—Vertigo—Prednisone—systemic scleroderma	0.000112	0.00036	CcSEcCtD
Allopurinol—Eye disorder—Methotrexate—systemic scleroderma	0.000111	0.00036	CcSEcCtD
Allopurinol—Tinnitus—Methotrexate—systemic scleroderma	0.000111	0.000359	CcSEcCtD
Allopurinol—Cardiac disorder—Methotrexate—systemic scleroderma	0.000111	0.000358	CcSEcCtD
Allopurinol—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.00011	0.000356	CcSEcCtD
Allopurinol—Vomiting—Lisinopril—systemic scleroderma	0.000109	0.000351	CcSEcCtD
Allopurinol—Immune system disorder—Methotrexate—systemic scleroderma	0.000108	0.000348	CcSEcCtD
Allopurinol—Rash—Lisinopril—systemic scleroderma	0.000108	0.000348	CcSEcCtD
Allopurinol—Convulsion—Prednisone—systemic scleroderma	0.000108	0.000348	CcSEcCtD
Allopurinol—Dermatitis—Lisinopril—systemic scleroderma	0.000108	0.000347	CcSEcCtD
Allopurinol—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000107	0.000347	CcSEcCtD
Allopurinol—Hypertension—Prednisone—systemic scleroderma	0.000107	0.000346	CcSEcCtD
Allopurinol—Chills—Methotrexate—systemic scleroderma	0.000107	0.000346	CcSEcCtD
Allopurinol—Headache—Lisinopril—systemic scleroderma	0.000107	0.000345	CcSEcCtD
Allopurinol—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000106	0.000342	CcSEcCtD
Allopurinol—Arthralgia—Prednisone—systemic scleroderma	0.000106	0.000342	CcSEcCtD
Allopurinol—Myalgia—Prednisone—systemic scleroderma	0.000106	0.000342	CcSEcCtD
Allopurinol—Alopecia—Methotrexate—systemic scleroderma	0.000105	0.00034	CcSEcCtD
Allopurinol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000105	0.000339	CcSEcCtD
Allopurinol—Discomfort—Prednisone—systemic scleroderma	0.000105	0.000338	CcSEcCtD
Allopurinol—Mental disorder—Methotrexate—systemic scleroderma	0.000105	0.000337	CcSEcCtD
Allopurinol—Malnutrition—Methotrexate—systemic scleroderma	0.000104	0.000335	CcSEcCtD
Allopurinol—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000102	0.000331	CcSEcCtD
Allopurinol—Dysgeusia—Methotrexate—systemic scleroderma	0.000102	0.000328	CcSEcCtD
Allopurinol—Nausea—Lisinopril—systemic scleroderma	0.000101	0.000328	CcSEcCtD
Allopurinol—Anaphylactic shock—Prednisone—systemic scleroderma	0.000101	0.000327	CcSEcCtD
Allopurinol—Oedema—Prednisone—systemic scleroderma	0.000101	0.000327	CcSEcCtD
Allopurinol—Infection—Prednisone—systemic scleroderma	0.000101	0.000325	CcSEcCtD
Allopurinol—Nervous system disorder—Prednisone—systemic scleroderma	9.95e-05	0.000321	CcSEcCtD
Allopurinol—Dizziness—Mycophenolate mofetil—systemic scleroderma	9.89e-05	0.000319	CcSEcCtD
Allopurinol—Skin disorder—Prednisone—systemic scleroderma	9.85e-05	0.000318	CcSEcCtD
Allopurinol—Hyperhidrosis—Prednisone—systemic scleroderma	9.81e-05	0.000317	CcSEcCtD
Allopurinol—Anorexia—Prednisone—systemic scleroderma	9.67e-05	0.000312	CcSEcCtD
Allopurinol—Ill-defined disorder—Methotrexate—systemic scleroderma	9.64e-05	0.000311	CcSEcCtD
Allopurinol—Anaemia—Methotrexate—systemic scleroderma	9.6e-05	0.00031	CcSEcCtD
Allopurinol—Vomiting—Mycophenolate mofetil—systemic scleroderma	9.51e-05	0.000307	CcSEcCtD
Allopurinol—Rash—Mycophenolate mofetil—systemic scleroderma	9.43e-05	0.000305	CcSEcCtD
Allopurinol—Dermatitis—Mycophenolate mofetil—systemic scleroderma	9.43e-05	0.000304	CcSEcCtD
Allopurinol—Headache—Mycophenolate mofetil—systemic scleroderma	9.37e-05	0.000303	CcSEcCtD
Allopurinol—Malaise—Methotrexate—systemic scleroderma	9.37e-05	0.000302	CcSEcCtD
Allopurinol—Vertigo—Methotrexate—systemic scleroderma	9.33e-05	0.000301	CcSEcCtD
Allopurinol—Leukopenia—Methotrexate—systemic scleroderma	9.3e-05	0.0003	CcSEcCtD
Allopurinol—Musculoskeletal discomfort—Prednisone—systemic scleroderma	9.24e-05	0.000298	CcSEcCtD
Allopurinol—Insomnia—Prednisone—systemic scleroderma	9.17e-05	0.000296	CcSEcCtD
Allopurinol—Paraesthesia—Prednisone—systemic scleroderma	9.11e-05	0.000294	CcSEcCtD
Allopurinol—Convulsion—Methotrexate—systemic scleroderma	9e-05	0.000291	CcSEcCtD
Allopurinol—Dyspepsia—Prednisone—systemic scleroderma	8.93e-05	0.000288	CcSEcCtD
Allopurinol—Nausea—Mycophenolate mofetil—systemic scleroderma	8.89e-05	0.000287	CcSEcCtD
Allopurinol—Arthralgia—Methotrexate—systemic scleroderma	8.84e-05	0.000285	CcSEcCtD
Allopurinol—Myalgia—Methotrexate—systemic scleroderma	8.84e-05	0.000285	CcSEcCtD
Allopurinol—Decreased appetite—Prednisone—systemic scleroderma	8.82e-05	0.000285	CcSEcCtD
Allopurinol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	8.78e-05	0.000284	CcSEcCtD
Allopurinol—Discomfort—Methotrexate—systemic scleroderma	8.74e-05	0.000282	CcSEcCtD
Allopurinol—Constipation—Prednisone—systemic scleroderma	8.67e-05	0.00028	CcSEcCtD
Allopurinol—Confusional state—Methotrexate—systemic scleroderma	8.55e-05	0.000276	CcSEcCtD
Allopurinol—Anaphylactic shock—Methotrexate—systemic scleroderma	8.48e-05	0.000274	CcSEcCtD
Allopurinol—Infection—Methotrexate—systemic scleroderma	8.42e-05	0.000272	CcSEcCtD
Allopurinol—Feeling abnormal—Prednisone—systemic scleroderma	8.36e-05	0.00027	CcSEcCtD
Allopurinol—Nervous system disorder—Methotrexate—systemic scleroderma	8.31e-05	0.000268	CcSEcCtD
Allopurinol—Thrombocytopenia—Methotrexate—systemic scleroderma	8.3e-05	0.000268	CcSEcCtD
Allopurinol—Gastrointestinal pain—Prednisone—systemic scleroderma	8.29e-05	0.000268	CcSEcCtD
Allopurinol—Skin disorder—Methotrexate—systemic scleroderma	8.23e-05	0.000266	CcSEcCtD
Allopurinol—Hyperhidrosis—Methotrexate—systemic scleroderma	8.19e-05	0.000265	CcSEcCtD
Allopurinol—Anorexia—Methotrexate—systemic scleroderma	8.08e-05	0.000261	CcSEcCtD
Allopurinol—Urticaria—Prednisone—systemic scleroderma	8.06e-05	0.00026	CcSEcCtD
Allopurinol—Body temperature increased—Prednisone—systemic scleroderma	8.02e-05	0.000259	CcSEcCtD
Allopurinol—Abdominal pain—Prednisone—systemic scleroderma	8.02e-05	0.000259	CcSEcCtD
Allopurinol—Hypotension—Methotrexate—systemic scleroderma	7.92e-05	0.000256	CcSEcCtD
Allopurinol—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	7.72e-05	0.000249	CcSEcCtD
Allopurinol—Insomnia—Methotrexate—systemic scleroderma	7.67e-05	0.000248	CcSEcCtD
Allopurinol—Paraesthesia—Methotrexate—systemic scleroderma	7.61e-05	0.000246	CcSEcCtD
Allopurinol—Somnolence—Methotrexate—systemic scleroderma	7.54e-05	0.000243	CcSEcCtD
Allopurinol—Hypersensitivity—Prednisone—systemic scleroderma	7.47e-05	0.000241	CcSEcCtD
Allopurinol—Dyspepsia—Methotrexate—systemic scleroderma	7.46e-05	0.000241	CcSEcCtD
Allopurinol—Decreased appetite—Methotrexate—systemic scleroderma	7.37e-05	0.000238	CcSEcCtD
Allopurinol—Gastrointestinal disorder—Methotrexate—systemic scleroderma	7.32e-05	0.000236	CcSEcCtD
Allopurinol—Asthenia—Prednisone—systemic scleroderma	7.28e-05	0.000235	CcSEcCtD
Allopurinol—Pain—Methotrexate—systemic scleroderma	7.25e-05	0.000234	CcSEcCtD
Allopurinol—Pruritus—Prednisone—systemic scleroderma	7.18e-05	0.000232	CcSEcCtD
Allopurinol—Feeling abnormal—Methotrexate—systemic scleroderma	6.99e-05	0.000226	CcSEcCtD
Allopurinol—Diarrhoea—Prednisone—systemic scleroderma	6.94e-05	0.000224	CcSEcCtD
Allopurinol—Gastrointestinal pain—Methotrexate—systemic scleroderma	6.93e-05	0.000224	CcSEcCtD
Allopurinol—Urticaria—Methotrexate—systemic scleroderma	6.73e-05	0.000217	CcSEcCtD
Allopurinol—Dizziness—Prednisone—systemic scleroderma	6.71e-05	0.000217	CcSEcCtD
Allopurinol—Abdominal pain—Methotrexate—systemic scleroderma	6.7e-05	0.000216	CcSEcCtD
Allopurinol—Body temperature increased—Methotrexate—systemic scleroderma	6.7e-05	0.000216	CcSEcCtD
Allopurinol—Vomiting—Prednisone—systemic scleroderma	6.45e-05	0.000208	CcSEcCtD
Allopurinol—Rash—Prednisone—systemic scleroderma	6.4e-05	0.000206	CcSEcCtD
Allopurinol—Dermatitis—Prednisone—systemic scleroderma	6.39e-05	0.000206	CcSEcCtD
Allopurinol—Headache—Prednisone—systemic scleroderma	6.35e-05	0.000205	CcSEcCtD
Allopurinol—Hypersensitivity—Methotrexate—systemic scleroderma	6.25e-05	0.000202	CcSEcCtD
Allopurinol—Asthenia—Methotrexate—systemic scleroderma	6.08e-05	0.000196	CcSEcCtD
Allopurinol—Nausea—Prednisone—systemic scleroderma	6.02e-05	0.000195	CcSEcCtD
Allopurinol—Pruritus—Methotrexate—systemic scleroderma	6e-05	0.000194	CcSEcCtD
Allopurinol—Diarrhoea—Methotrexate—systemic scleroderma	5.8e-05	0.000187	CcSEcCtD
Allopurinol—Dizziness—Methotrexate—systemic scleroderma	5.61e-05	0.000181	CcSEcCtD
Allopurinol—Vomiting—Methotrexate—systemic scleroderma	5.39e-05	0.000174	CcSEcCtD
Allopurinol—Rash—Methotrexate—systemic scleroderma	5.34e-05	0.000173	CcSEcCtD
Allopurinol—Dermatitis—Methotrexate—systemic scleroderma	5.34e-05	0.000172	CcSEcCtD
Allopurinol—Headache—Methotrexate—systemic scleroderma	5.31e-05	0.000171	CcSEcCtD
Allopurinol—Nausea—Methotrexate—systemic scleroderma	5.03e-05	0.000163	CcSEcCtD
